台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    23.85
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    311
  • 產業
    上櫃 生技醫療類股
  • 150人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
健亞 (4130)籌碼相關-凱基-澄新 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-澄新 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2019/11/0100.00524.6024.55-5131-3.81%
2019/10/18524.1500.0024.0051373.64%
2019/09/16426.3500.0026.3541782.25%
2019/08/07626.4400.0026.3061943.08%
2019/08/0500.00226.4526.35-2194-1.03%
2019/07/1700.00628.0028.00-6170-3.51%
2019/07/16129.4500.0029.5011650.60%
2019/07/11529.1600.0029.0051523.28%
2019/04/09329.7000.0029.7034190.71%
2019/03/0700.00331.0030.85-3405-0.74%
2019/02/2500.00029.9029.700376-0.01%
2019/02/192130.982130.2030.2003630.00%
2019/02/15330.0000.0030.0033410.88%
2019/02/1400.00529.3029.40-5292-1.71%
2019/02/1200.00228.6328.65-2278-0.72%
2019/01/17228.6800.0028.6023010.66%
2019/01/15128.9000.0028.8513030.33%
2019/01/14128.7000.0028.7013040.33%
2019/01/10130.2500.0029.6013040.33%
2019/01/08129.6500.0031.2012920.34%
2018/12/25128.3000.0028.4014100.24%
2018/11/0200.00627.9527.80-61,170-0.51%
2018/10/11328.9000.0028.3031,1240.27%
2018/10/08331.4000.0032.0031,0850.28%
2018/10/05633.49633.7532.7001,0730.00%
2018/10/04633.05433.8133.4521,0180.20%
2018/10/031533.5700.0033.35151,0061.49%
2018/09/27535.9200.0034.9058720.57%
2018/09/0700.00232.0532.05-2274-0.73%
2018/08/1000.00130.8030.70-1317-0.32%
2018/07/0300.00232.6532.20-2877-0.23%
2018/05/3100.00134.5035.10-11,556-0.06%
2018/05/1700.00335.9735.90-31,534-0.20%
2018/05/1600.00136.5536.55-11,527-0.07%
2018/05/1500.002336.1736.10-231,514-1.52%
2018/05/1400.002036.0536.00-201,516-1.32%
2018/05/1100.00536.1035.95-51,513-0.33%
2018/05/08237.3000.0037.5021,4860.13%
2018/04/2600.00438.3035.60-41,419-0.28%
2018/04/25235.9000.0037.2521,3990.14%
2018/04/24637.6000.0036.6561,3850.43%
2018/04/23238.30238.9038.6001,3690.00%
2018/04/16537.7000.0037.6551,3400.37%
2018/04/13238.4000.0037.7021,3260.15%
2018/04/10439.23441.6838.6001,2400.00%
2018/04/09639.3000.0040.5061,1350.53%
2018/04/034639.731639.6439.35301,0682.81%
2018/03/31338.1000.0037.9038730.34%
2018/03/30236.9500.0036.8028330.24%
2018/03/27638.16537.9537.4017160.14%
2018/03/2600.001037.4037.40-10588-1.70%
2018/03/23233.4000.0034.0024940.40%
2018/03/0700.00233.8534.00-2402-0.50%
2018/02/26233.0000.0032.9024100.49%
2018/01/26234.1500.0034.8025930.34%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章